CEO Matthew Weinberg Presents at FDA Clinical Trials Hearing

April 23, 2012

April 23 - The Weinberg Group CEO, Matthew Weinberg, presented today at FDA’s hearing titled “Modernizing the Regulation of Clinical Trials and Approaches to Good Clinical Practice.”  Mr. Weinberg presented on the mandatory need for audits and audit independence.  A full copy of his presentation can be found below.

For more information on The Weinberg Group’s independent clinical auditing services, please contact
Jeff Antos, Vice President, at jeff.antos@weinberggroup.com or 202.280.0815.




April 23, 2012

The Weinberg Group CEO to Speak at AIPPI’s International Convention on the Economy of Innovation

WASHINGTON, DC – April 17, 2018 – Matthew Weinberg, Chief Executive Officer of The Weinberg Group Inc., will be speaking at the International Association for the Protection of Intellectual Property’s...

Read More

April 23, 2012

Matthew Weinberg Writes for Tobacco Reporter

CEO Matthew Weinberg writes for Tobacco Reporter Magazine encouraging stakeholders to take advantage of the opportunity to respond to FDA e-cigarette regulations.

Read More

April 23, 2012

Matthew Weinberg Writes for International Clinical Trials (ICT) Magazine

In this article CEO Matthew Weinberg discusses the downsides to self-auditing good clinical practice and the need smaller, more proactive audits, on the other hand, can provide a more intelligent...

Read More